AQP4 Protein — Aquaporin 4

Pathway Diagram

flowchart TD
    AQP4["AQUAPORIN-4<br/>Water Channel Protein"]
    
    GS["Glymphatic System<br/>Brain Clearance"]
    NMOSD["Neuromyelitis Optica<br/>Spectrum Disorder"]
    CNS["Central Nervous<br/>System Disorders"]
    
    MS["Multiple Sclerosis"]
    ALS["Amyotrophic Lateral<br/>Sclerosis"]
    AD["Alzheimer's Disease"]
    PD["Parkinson's Disease"]
    
    NI["Neuroinflammation"]
    AI["Autoimmune<br/>Response"]
    INF["Inflammation"]
    ND["Neurodegeneration"]
    
    AGING["Aging Process"]
    
    AQP4 --"facilitates"--> GS
    AQP4 --"target antigen"--> NMOSD
    AQP4 --"dysfunction in"--> CNS
    
    AQP4 --"activates/regulates"--> MS
    AQP4 --"dual role in"--> ALS
    AQP4 --"associated with"--> AD
    AQP4 --"inhibits"--> PD
    
    AQP4 --"regulates"--> NI
    AQP4 --"dual role in"--> AI
    AQP4 --"modulates"--> INF
    AQP4 --"involved in"--> ND
    
    AQP4 --"regulates"--> AGING
    
    GS --"impaired clearance"--> ND
    NI --"promotes"--> ND
    AI --"drives"--> NMOSD
    
    style AQP4 fill:#006494
    style GS fill:#1b5e20
    style NMOSD fill:#ef5350
    style CNS fill:#ef5350
    style MS fill:#ef5350
    style ALS fill:#ef5350
    style AD fill:#ef5350
    style PD fill:#1b5e20
    style NI fill:#ef5350
    style AI fill:#ef5350
    style INF fill:#ef5350
    style ND fill:#5d4400
    style AGING fill:#4a1a6b

Overview

Aquaporin-4 (AQP4) is the principal water channel in the brain, highly expressed in astrocyte end-feet that surround cerebral blood vessels and in ependymal cells lining the ventricles^{1AQP4 in brain (2003)2003 · PMID 12665610Open reference}. AQP4 plays a critical role in glymphatic clearance—a brain-wide waste clearance system that removes metabolic byproducts, toxic proteins, and interstitial solutes during sleep^{2Glymphatic clearance of Aβ (2012)2012 · DOI 10.1126/science.1220363Open reference}. Dysregulation of AQP4 has been implicated in Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, traumatic brain injury (TBI), and multiple sclerosis (MS)^{3Papadopoulos & Verkman, AQP4 in brain disorders (2013)2013 · DOI 10.1038/nrm3520Open reference4AQP4 in Parkinson's disease (2018)2018 · PMID 29526542Open reference}. The protein forms orthogonal arrays of particles (OAPs) in the plasma membrane that mediate rapid water flux between the cerebrospinal fluid (CSF) and interstitial fluid (ISF).

Structure

AQP4 exists as two major isoforms:

• M1 isoform (323 aa): Contains the full sequence, localizes to both astrocyte cell bodies and end-feet

• M23 isoform (323 aa): Truncated at the N-terminus, organizes into larger OAPs and is primarily end-foot localized

The protein forms tetramers that assemble into larger orthogonal arrays:

• Monomer: Six transmembrane alpha-helices with cytoplasmic N- and C-termini

• Tetramer: Four monomers form a functional water channel (~4 water molecules per nanosecond)

• OAP (Orthogonal Array of Particles): Multiple tetramers cluster to form large assemblies visible by freeze-fracture electron microscopy

The M23 isoform has a shorter N-terminus that lacks the palmitoylation sites present in M1, allowing more efficient OAP formation^{5AQP4 structure and assembly (1994)1994 · DOI 10.1126/science.7512454Open reference}.

Normal Function

Water Homeostasis

AQP4 mediates rapid water transport across the blood-brain barrier:

• Glymphatic clearance: CSF flows into the brain along perivascular spaces, then water exits through AQP4 into the interstitium

• Astrocyte volume regulation: AQP4 helps maintain optimal astrocyte hydration

• CSF-ISF exchange: Facilitates bidirectional water flow between fluid compartments

Potassium Buffering

AQP4 works with Kir4.1 potassium channels to buffer extracellular potassium:

• During neuronal activity, potassium is released into the extracellular space

• AQP4-mediated water flux helps disperse potassium

• Coordinated with Kir4.1 for efficient potassium clearance^{6Kofuji & Newman, AQP4 and Kir4.1 buffering (2009)2009 · PMID 19447094Open reference}

Neuroinflammation

AQP4 plays complex roles in neuroinflammation:

• Upregulated in reactive astrocytes surrounding lesions

• Involved in edema formation during inflammation

• Regulates immune cell trafficking across the BBB

Role in Disease

Alzheimer’s Disease

AQP4 dysfunction significantly impacts AD pathogenesis:

• Impaired amyloid clearance: AQP4 deficiency reduces Aβ clearance by ~40%^{2Glymphatic clearance of Aβ (2012)2012 · DOI 10.1126/science.1220363Open reference}

• Perivascular AQP4 loss: Reduced AQP4 expression around cerebral vessels in AD patients

• Glymphatic impairment: Sleep-dependent Aβ clearance is AQP4-dependent

• Tau pathology: AQP4 dysfunction may exacerbate tau spread via glymphatic pathways

Parkinson’s Disease

AQP4 influences PD through multiple mechanisms:

• Alpha-synuclein clearance: Glymphatic system removes extracellular α-syn

• Impaired clearance in PD: Reduced AQP4 expression observed in PD models

• Blood-brain barrier leakage: AQP4 dysregulation contributes to BBB breakdown

• Neuroinflammation: AQP4 affects microglial activation states^{4AQP4 in Parkinson's disease (2018)2018 · PMID 29526542Open reference}

Stroke and Traumatic Brain Injury

AQP4 has dual roles in acute brain injury:

• Early phase: Contributes to cytotoxic edema (cell swelling)

• Late phase: Facilitates vasogenic edema resolution

• Therapeutic window: Modulating AQP4 can reduce injury if timed correctly

Multiple Sclerosis

AQP4 is the autoantigen in neuromyelitis optica (NMO):

• Autoantibodies against AQP4 cause demyelination

• Loss of AQP4 in lesion centers

• Astrocyte dysfunction precedes demyelination^{7AQP4 autoantibody in NMO (2005)2005 · DOI 10.1084/jem.20051903Open reference}

Therapeutic Implications

AQP4 represents a therapeutic target for several conditions:

• Glymphatic enhancement: Compounds that increase AQP4 expression or activity could improve waste clearance in AD/PD

• Sleep modulation: Optimizing sleep architecture enhances AQP4-mediated glymphatic clearance

• Anti-AQP4 antibodies: For NMO treatment, approaches to block pathogenic antibodies

• Edema management: AQP4 modulators for stroke and TBI

• Gene therapy: AAV-mediated AQP4 expression for neurodegenerative diseases^{8AQP4 as therapeutic target (2016)2016 · DOI 10.1016/j.tips.2016.04.013Open reference}

Interactions

AQP4 interacts with:

• Kir4.1 (KCNJ10): Potassium channel coordinate for potassium/water buffering

• Dystroglycan complex: Anchor at astrocyte end-feet

• Mitochondrial proteins: AQP4 localizes to some mitochondrial membranes

• Cytoskeletal proteins: Interaction with actin for membrane anchoring

See Also

• AQP4 Gene

• Glymphatic System

• Astrocytes in Neurodegeneration

• Alzheimer’s Disease

• Parkinson’s Disease

External Links

• UniProt: P55064

• GeneCards: AQP4

• OMIM: 600030

• Allen Brain Atlas: AQP4 expression